JP2022543320A5 - - Google Patents
Info
- Publication number
- JP2022543320A5 JP2022543320A5 JP2022507761A JP2022507761A JP2022543320A5 JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5 JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- complex according
- complex
- peptide carrier
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1911403.2 | 2019-08-09 | ||
| GBGB1911403.2A GB201911403D0 (en) | 2019-08-09 | 2019-08-09 | Conjugate and uses thereof |
| PCT/GB2020/051891 WO2021028666A1 (en) | 2019-08-09 | 2020-08-07 | Conjugate and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543320A JP2022543320A (ja) | 2022-10-11 |
| JP2022543320A5 true JP2022543320A5 (https=) | 2023-08-14 |
| JP7678654B2 JP7678654B2 (ja) | 2025-05-16 |
Family
ID=67990936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507761A Active JP7678654B2 (ja) | 2019-08-09 | 2020-08-07 | 複合体及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220275372A1 (https=) |
| EP (1) | EP4010030A1 (https=) |
| JP (1) | JP7678654B2 (https=) |
| KR (1) | KR20220079524A (https=) |
| CN (2) | CN114615998B (https=) |
| AU (1) | AU2020327659A1 (https=) |
| BR (1) | BR112022002309A2 (https=) |
| CA (1) | CA3149700A1 (https=) |
| GB (1) | GB201911403D0 (https=) |
| IL (1) | IL290424A (https=) |
| MX (1) | MX2022001712A (https=) |
| SA (1) | SA522431627B1 (https=) |
| WO (1) | WO2021028666A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200131231A1 (en) | 2017-02-17 | 2020-04-30 | Oxford University Innovation Limited | Cell penetrating peptides |
| GB201812980D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| GB201812972D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| US12465646B2 (en) | 2018-12-07 | 2025-11-11 | Oxford University Innovation Limited | Linkers |
| WO2022171972A1 (en) * | 2021-02-12 | 2022-08-18 | Oxford University Innovation Limited | Cell-penetrating peptide conjugates and methods of their use |
| EP4304657A4 (en) * | 2021-03-12 | 2026-04-01 | Pepgen Inc | METHODS OF TREATMENT OF TYPE 1 MYOTONIC DYSTROPHY USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES |
| KR20250116673A (ko) * | 2022-11-21 | 2025-08-01 | 펩젠 인크. | 세포-침투 펩티드, 그의 접합체 및 그의 사용 방법 |
| WO2025033255A1 (ja) * | 2023-08-07 | 2025-02-13 | 東亞合成株式会社 | ペプチドフラグメント及びその利用 |
| WO2025033256A1 (ja) * | 2023-08-07 | 2025-02-13 | 東亞合成株式会社 | ペプチドフラグメント及びその利用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2049664T1 (sl) * | 2006-08-11 | 2012-04-30 | Prosensa Technologies Bv | Enojna veriga oligonukleotidov, komplementarna repetitivnim elementom, za zdravljenje genetskih bolezni, povezanih z nestabilnostjo dnk ponovitev |
| WO2009005793A2 (en) * | 2007-06-29 | 2009-01-08 | Avi Biopharma, Inc. | Tissue specific peptide conjugates and methods |
| US20100016215A1 (en) * | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| WO2009147368A1 (en) * | 2008-06-04 | 2009-12-10 | Medical Research Council | Peptides |
| US20110269665A1 (en) * | 2009-06-26 | 2011-11-03 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| CN103998458B (zh) * | 2011-08-30 | 2018-10-09 | 医学研究理事会 | 具有中央疏水域的细胞穿透肽 |
| EP2900821B1 (en) * | 2012-09-25 | 2020-04-01 | Genzyme Corporation | Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy |
| RU2708237C2 (ru) | 2014-08-22 | 2019-12-05 | Общество с ограниченной ответственностью "НооГен" | Модифицированные олигонуклеотиды и способ их получения |
-
2019
- 2019-08-09 GB GBGB1911403.2A patent/GB201911403D0/en not_active Ceased
-
2020
- 2020-08-07 AU AU2020327659A patent/AU2020327659A1/en active Pending
- 2020-08-07 JP JP2022507761A patent/JP7678654B2/ja active Active
- 2020-08-07 CN CN202080071067.8A patent/CN114615998B/zh active Active
- 2020-08-07 CA CA3149700A patent/CA3149700A1/en active Pending
- 2020-08-07 MX MX2022001712A patent/MX2022001712A/es unknown
- 2020-08-07 KR KR1020227007655A patent/KR20220079524A/ko active Pending
- 2020-08-07 EP EP20754817.3A patent/EP4010030A1/en active Pending
- 2020-08-07 CN CN202510582562.XA patent/CN120837670A/zh active Pending
- 2020-08-07 WO PCT/GB2020/051891 patent/WO2021028666A1/en not_active Ceased
- 2020-08-07 BR BR112022002309A patent/BR112022002309A2/pt unknown
- 2020-08-07 US US17/631,654 patent/US20220275372A1/en active Pending
-
2022
- 2022-02-07 IL IL290424A patent/IL290424A/en unknown
- 2022-02-08 SA SA522431627A patent/SA522431627B1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543320A5 (https=) | ||
| CN103998458B (zh) | 具有中央疏水域的细胞穿透肽 | |
| US8609065B2 (en) | Molecules for targeting compounds to various selected organs, tissues or tumor cells | |
| JP2021534131A5 (https=) | ||
| US20220090066A1 (en) | Cell penetrating molecule | |
| Tung et al. | Preparation and applications of peptide− oligonucleotide conjugates | |
| JP7678654B2 (ja) | 複合体及びその使用 | |
| AU2005247460B2 (en) | Peptide conjugated, inosine-substituted antisense oligomer compound and method | |
| WO2023026994A1 (ja) | ヒトトランスフェリンレセプター結合ペプチド－薬物コンジュゲート | |
| RU2011129861A (ru) | Новые конструкции транспортеров и молекулы-конъюгаты, являющиеся транспортерами карго-молекул | |
| CA2482598A1 (en) | Peptide inhibitors of protein kinase c | |
| WO1997012912A1 (fr) | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives | |
| JP2025508337A5 (https=) | ||
| Debart et al. | Chemical modifications to improve the cellular uptake of oligonucleotides | |
| RU2022105559A (ru) | Конъгат и его применения | |
| WO2001027261A2 (en) | Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino | |
| US20230399378A1 (en) | Peptide-based delivery of agents | |
| ES2465569T3 (es) | Proteína de fusión de melusina recombinante como agente farmacológico en el tratamiento de patologías cardiacas y composiciones de la misma | |
| RU2025116420A (ru) | Проникающие в клетку пептиды, их конъюгаты и способы их применения | |
| HK40075520B (zh) | 缀合物及其用途 | |
| US20210024583A1 (en) | Compositions and methods for peptide mediated oligonucleotide delivery to the central nervous system | |
| WO2025229308A1 (en) | Conjugate for treating repeat expansion disorders | |
| RU2023123089A (ru) | Проникающие в клетки пептидные конъюгаты | |
| HK40075520A (zh) | 缀合物及其用途 | |
| RU2021105152A (ru) | Проникающие в клетку пептиды |